PDF-Guidance for Industry Limiting the Use of Certain Phthalates as Excipients in CDER Regulated PDF document

S Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research CDER December 201 CMC brPage 2br Guidance for Industry

Upload by faustina-dinatale
Published on 2014-12-17

Presentation Embed Code

<iframe width="560" height="315" src="https://www.docslides.com/embed/25334" frameborder="0" allowfullscreen></iframe>

Download Presentation

Download Presentation The PPT/PDF document "Guidance for Industry Limiting the Use o..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Guidance for Industry Limiting the Use of Certain Phthalates as Excipients in CDER Regulated: Transcript

PDF-Guidance for Industry Limiting the Use of Certain Phthalates as Excipients in CDER Regulated PDF document

Presentation Embed Code

Download Presentation

Guidance for Industry Limiting the Use of Certain Phthalates as Excipients in CDER Regulated: Transcript

Related Contents

Guidance for Industry Adverse Reactions Section of Labeling for Huma

Guidance for Industry Developing Products for Weight Management DRAFT GUIDANCE This guidance

Guidance for Industry Applications for Premarket Review of New Tobacco Products DRAFT

Guidance for Industry Considerations for the Design of Early Phase Clinical Trials of

Hyun Jung Koo, Byung Mu Lee

Guidance for Industry Naming of Drug Products Containing Salt Drug Substances DRAFT GUIDANCE

Guidance for Industry Circumstances that Constitute Delaying Denying Limiting or Refusing

Guidance for Industry Chronic Fatigue Syndrome Myalgic Encephalomyelitis Developing Drug

Guidance for Industry Regulation of Human Cells Tissues and Cellular and TissueBased Products

Guidance for IndustryLimitingthe Use of Certain Phthalates as Excipien

Not TooPretty

Guidance for Industry Q3B(R2) Impurities in New Drug Products

FORMULATION OF LEVOFLOXACIN AS ORODISPERSIBLE TABLETS USING A READY-MADE BLEND OF EXCIPIENTS

Guidance for Industry OrganSpecific Warnings Internal Analgesic Antipyretic and Antirheumatic